home All News open_in_new Full Article

Motilal Oswal Maintains 'Buy' On Piramal Pharma Despite Near

Motilal Oswal maintains a 'Buy' rating on Piramal Pharma and revises target price, implying a 20% upside.


today 2 w. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics


ID: 2837370966
Add Watch Country

arrow_drop_down